Spotted
Research type
Research Study
Full title
Second Primary Tumour Early Detection
IRAS ID
209606
Contact name
Robert Rintoul
Contact email
Sponsor organisation
Papworth Hospital NHS Foundation Trust
Duration of Study in the UK
1 years, 6 months, 0 days
Research summary
Improvements in cancer treatment have translated into an increasing population of lung cancer survivors who are at risk of subsequent cancers - particularly smoking-related cancers. However, the risk of subsequent cancer among lung cancer suvivors is currently poorly understood. Furthermore, factors associated with higher risk of subsequent cancer are also not known.
Using data from the Public Health England's National Cancer Registration Service we will examine patterns of risk of subsequent cancer in patients with lung and other smoking-related cancers. Understanding these new patterns of disease following successful cancer treatment and rapidly increasing numbers of disease-free survivors is an area of unmet need with significant clinical and health economic implications. A better appreciation of the natural history of second primary cancers should lead to improvements in surveillance regimes, leading to earlier detection, better treatment and improved longer-term outcomes for these patients.
REC name
London - Riverside Research Ethics Committee
REC reference
16/LO/1383
Date of REC Opinion
22 Aug 2016
REC opinion
Further Information Favourable Opinion